Houstonmom iconHoustonmomSep 2, 2026 ~7 min source read

More than a Gold Ribbon: Families, Loss, and Life After Childhood Cancer

A Houston mother recounts her son RJ’s 3.5-year fight with rhabdomyosarcoma, shares other families’ journeys, and urges remembrance, listening, and advocacy during Childhood Cancer Awareness Month.

More than a Gold Ribbon: The Children and Families Behind Childhood Cancer

Share this story

Send the public story page.

Useful takeaways from this story.

Clinical trials can change standards of care: one family’s child received immunotherapy in a trial that later became FDA-approved for B-cell ALL.

Hospital communities—other parents, staff, and fellow patients—often become critical emotional and practical support networks during long treatments.

Awareness month is presented as a time to remember children lost to cancer, support families still fighting, and use personal stories to advocate for better care.

# Cancer

What the story reports

The piece centers memory and action. Though RJ has died, his mother continues to advocate in his name—raising awareness, supporting other families, and keeping the memory of the children alive by saying their names.

A concrete example: Juliana's case

One family shared in detail: Juliana, age 4 in late 2021, developed fevers, appetite loss, extreme sleepiness, and leg pain that was first mistaken for growing pains. When pallor prompted bloodwork, results led to an urgent trip to Texas Children's on December 29. She was diagnosed with B-cell acute lymphoblastic leukemia (ALL) and admitted to the ICU with dangerously low hemoglobin, requiring multiple transfusions.

Much of Juliana's care occurred outpatient, but she had unexpected readmissions and hard days. Her family enrolled her in an immunotherapy clinical trial with continuous treatments lasting between two and 28 days. About a year after she completed treatment, that therapy received FDA approval and became standard of care for B-cell leukemia. After two and a half years of treatment, Juliana rang the cancer bell in March 2024 and returned to a more typical childhood routine as a fourth-grader.

Themes that matter to families

  • Treatment is lengthy and disruptive. Even when care is outpatient, families face repeated hospital stays, transfusions, and clinical procedures.
  • Clinical trials can bring hope and later broader benefits when successful therapies are approved.
  • Grief continues after death. Parents who lose a child often channel their experience into advocacy and memory work.

Call to action for September

The writer frames September as Childhood Cancer Awareness Month and asks readers to do three practical things: remember the children who fought, listen to the families who live with these stories, and advocate for continued support and research. Saying each child's name is presented as a concrete practice to keep memory and momentum alive.

The piece aims to move readers beyond the gold ribbon symbol to the lived realities—treatment timelines, clinical trial journeys, the social networks formed in hospital corridors, and the lifelong emotional consequences for families.

More context around this story.

Loading more related stories...

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app